Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,430.00    45.00 (0.61%)
Bid:
7,410.00
Ask:
7,415.00
Spread: 5.00 (0.067%)
Market Cap: £32.90b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

SID Appointment and Board Committee Changes

10 Apr 2026 11:00

RNS Number : 0137A
Coca-Cola Europacific Partners plc
10 April 2026
 

SENIOR INDEPENDENT DIRECTOR APPOINTMENT AND

CHANGES IN COMPOSITION OF THE BOARD COMMITTEES

 

The Board of Directors of Coca-Cola Europacific Partners plc (CCEP) announces the following changes to the composition of the Board Committees with effect from the conclusion of the Annual General Meeting (AGM) to be held on 28 May 2026:

 

· Mary Harris, Independent Non-executive Director, will be appointed Senior Independent Director;

 

· Nathalie Gaveau, Independent Non-executive Director, will retire as a member of the Environmental, Social and Governance Committee;

 

· Dessi Temperley, Independent Non-executive Director, will be appointed as a member of the Environmental, Social and Governance Committee;

 

· Nicolas Mirzayantz, Independent Non-executive Director, will be appointed as a member of the Nomination Committee and will retire as a member of the Audit Committee;

 

· Mark Price, Independent Non-executive Director, will be appointed as Chairman of the Affiliated Transaction Committee; and

 

· subject to their formal appointment as Independent Non-executive Directors at the AGM:

 

Laurence Debroux and Uvashni Raman will be appointed as members of the Audit Committee;

Laurence Debroux will be appointed as a member of the Remuneration Committee; and

Uvashni Raman will be appointed as a member of the Affiliated Transaction Committee.

 

Following the changes noted above, the membership of the Committees will be as follows:

 

Audit Committee

Affiliated Transaction Committee

Environmental, Social and Governance Committee

Dessi Temperley (Chairman)

Mark Price (Chairman)

Mario Rotllant (Chairman)

Robert Appleby

Sol Daurella

Robert Appleby

John Bryant

Nathalie Gaveau

Nicolas Mirzayantz

Laurence Debroux

Alfonso Líbano Daurella

Dessi Temperley

Uvashni Raman

Uvashni Raman

Nancy Quan

   

Nomination Committee

Remuneration Committee

Mary Harris (Chairman)

John Bryant (Chairman)

Manolo Arroyo

Manolo Arroyo

Sol Daurella

José Ignacio Comenge

Nicolas Mirzayantz

Laurence Debroux

Mark Price

Mary Harris

 

This notification is made in accordance with UK Listing Rule 6.4.6R(3).

 

CONTACTS

 

Company Secretariat

Svetlana Walker

svetlana.walker@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANLEFENKEEA
Date   Source Headline
12th Jun 20264:30 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202612:30 pmRNSDirector/PDMR Shareholding
1st Jun 20261:30 pmRNSTotal Voting Rights
29th May 20261:00 pmRNSResult of AGM
21st May 20263:30 pmRNSDirector/PDMR Shareholding
18th May 202611:00 amRNSLetter to Shareholders
1st May 20264:15 pmRNSDirector/PDMR Shareholding
1st May 20261:30 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSQ1 Trading Update & Interim Dividend Declaration
27th Apr 20263:00 pmRNSTransactions in Own Shares
22nd Apr 20262:15 pmRNSDirector/PDMR Shareholding
20th Apr 20261:30 pmRNSTransactions in Own Shares
16th Apr 20269:15 amRNSNotice of AGM
15th Apr 202610:30 amRNSDirector/PDMR Shareholding
13th Apr 202612:30 pmRNSTransaction in Own Shares
10th Apr 202611:00 amRNSSID Appointment and Board Committee Changes
7th Apr 20262:00 pmRNSTransaction in Own Shares
1st Apr 20262:30 pmRNSTotal Voting Rights
1st Apr 202611:00 amRNSChange of Company Secretary
30th Mar 20263:30 pmRNSTransactions in Own Shares
27th Mar 20269:00 amRNSDirector/PDMR Shareholding
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransactions in Own Shares
20th Mar 20264:45 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransactions in Own Shares
19th Mar 20267:00 amRNSTransactions in Own Shares
18th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20265:00 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
11th Mar 20267:00 amRNSTransactions in Own Shares
10th Mar 20267:00 amRNSTransactions in Own Shares
9th Mar 20267:00 amRNSTransactions in Own Shares
6th Mar 20267:00 amRNSTransactions in Own Shares
5th Mar 20267:00 amRNSTransactions in Own Shares
4th Mar 20264:00 pmRNSDirectorate change
4th Mar 20267:00 amRNSTransactions in Own Shares
3rd Mar 20265:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:00 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSTransactions in Own Shares
2nd Mar 20261:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.